Skip to content
Parakho

Anlon Healthcare Ltd

NSE AHCLBSE 544497anlon.inInvestor relations

Q1 FY27, unaudited

Revenue
₹30.98 Cr
Profit after tax
₹4.80 Cr

As filed with the exchange, standalone basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, standalone basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations30.98−6.97%176.50
Other income0.06+409.40%0.25
Total income31.04−6.83%176.75
Employee benefit expense1.52+24.15%5.25
Finance costs0.96+17.93%4.35
Depreciation & amortisation0.66+54.15%1.36
Total expenses25.13−11.21%136.08
Profit before tax5.90+17.98%40.68
Tax expense1.11−24.06%12.87
Profit after tax4.80+35.25%27.81
Total comprehensive income4.78+34.76%27.76
Earnings per share
Earnings per share, basic₹0.09₹5.93
Earnings per share, diluted₹0.09₹5.93

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Q1 FY27 results for every company Parakho holds

Earnings call

Q4 FY26

Anlon Healthcare reported FY26 consolidated total income of INR 172.22 crore, up 42.98% year-on-year, with EBITDA up 47.55% and PAT up 41.77%. Q4 FY26 total income was INR 50.90 crore versus INR 48.97 crore a year earlier, while reported PAT of INR 11.07 crore was lower than INR 16.65 crore in the year-ago quarter due to higher operating and development expenses. Management discussed the completed acquisitions of Apiqo Organics and Bizotic Life Science, capacity expansion plans, and provided revenue and margin outlook for FY27 and FY28.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote.

Read the full summary

Filings

12 shown · 66 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Industry

Healthcare › Pharmaceuticals

Classification as published by BSE.

Companies also in Pharmaceuticals, in alphabetical order

All 196 companies in Pharmaceuticals

Page generated from filings held to 29 Sept 2026.